Q2 Earnings Estimate for TNDM Issued By Leerink Partnrs
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) – Equities research analysts at Leerink Partnrs lowered their Q2 2025 earnings per share (EPS) estimates for Tandem Diabetes Care in a research note issued to investors on Wednesday, April 30th. Leerink Partnrs analyst M. Kratky now expects that the medical device company will post earnings of […]
